Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis

    Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis
    Date: 21 Apr, 2017              Type: Vaccines              Pages: 383

    • Electronic Access - Single User License
      $1,990.00
    • CD-ROM Mail Delivery
      $2,090.00
    • Hard-copy Mail Delivery
      $2,190.00
    • Electronic Access - Multi User License
      $2,800.00

    Get Free 10% Customization in This Report

    Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period.

    United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine Market Share was almost 4 times more than China and Japan Influenza Vaccine Market Share. United States & China together captures close to 60 percent in Pediatrics Influenza Vaccine Market Share. Whereas, in adult vaccination segments, United States and Japan will share more than 50 percent market share by 2022.     

    Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis is the 8th report by Renub Research on Influenza Vaccine Market. This is a 383 page report with 386 Figures and 7 Tables provides data of 30 countries globally on Influenza Vaccine Market. The report provides data on Pediatrics and Adult Influenza Vaccinated Population Numbers and Market. All 30 Countries have been extensively studied from 2 major points, which has been further sub-divided into 2 more points:   

    1.    Influenza Vaccine Market & Forecast (2011 – 2022)

    a.    Pediatrics Influenza Vaccine Market & Forecast
    b.    Adult Influenza Vaccine Market & Forecast

    2.    Influenza Vaccinated Population & Forecast (2011 – 2022)

    a.    Pediatrics Influenza Vaccinated Population & Forecast
    b.    Adult Influenza Vaccinated Population & Forecast 


    30 Countries Influenza Vaccine Market covered in the report are as follows

     
    1.    United States
    2.    Netherlands
    3.    Denmark
    4.    Estonia
    5.    Finland
    6.    Germany
    7.    France
    8.    Hungary
    9.    Iceland
    10.    Ireland
    11.    Italy
    12.    Latvia
    13.    Lithuania
    14.    Luxembourg
    15.    Malta
    16.    Norway
    17.    Poland
    18.    Portugal
    19.    Romania
    20.    Slovakia
    21.    Slovenia
    22.    Spain
    23.    Sweden
    24.    United Kingdom
    25.    China
    26.    India
    27.    Brazil
    28.    Japan
    29.    Australia
    30.    New Zealand 

     

    This report offers the best viewpoint on the leading five influenza vaccine brands 

    1.    Vaxigrip/Fluzone
    2.    Fluarix/ Flulaval
    3.    FluMist/Fluenz
    4.    Afluria/Fluvax and Fluvirin/Flucelvax
    5.    Anflu

     

    Scope of Study

    •    Influenza Vaccine Market has been divided into two segments Pediatrics Influenza Vaccine Market and Adult Influenza Vaccine Market. 

    •    Influenza Vaccine Market share & Forecast, Pediatrics Influenza Vaccine Market share & Forecast and Adult Influenza Vaccine Market share & Forecast. 

    •   Influenza Vaccinated Population & Forecast has been divided into two segments Pediatrics Influenza Vaccinated Population & Forecast and Adult Influenza Vaccinated Population & Forecast.   

    •    Influenza Vaccine Brand Sales and Forecast

     

    This report is a combination of 6 reports

    1.    Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis
    2.    Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast 
    3.    Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult)
    4.    Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination 
    5.    Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia and Slovenia (East Europe) By (Infant & Adult) Forecast 
    6.    Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast

    1    Executive Summary

    2    Influenza – Introduction
    2.1    Different Types of Influenza Viruses
    2.1.1    Type A Flu Virus
    2.1.2    Type B Flu Virus
    2.1.3    Type C Flu Virus
    2.1.4    Type D Flu Virus

    2.2    An Influenza Pandemic

    3    Structure of Influenza Virus

    4    Notable Influenza Pandemics

    5    Worldwide Influenza Vaccinated Population
    5.1    Worldwide Seasonal Influenza Vaccinated Child Population

    5.2    Worldwide Seasonal Influenza Vaccinated Adult Population

    6    Worldwide Seasonal Influenza Vaccine Market
    6.1    Worldwide - Seasonal Influenza Child Vaccine Market

    6.2    Worldwide Seasonal Influenza Adult Vaccine Market

    7    Worldwide Seasonal Influenza Vaccine Market Share Analysis
    7.1    Worldwide Seasonal Influenza Vaccine Market Share

    7.2    Worldwide Seasonal Influenza Child Vaccine Market Share

    7.3    Worldwide Seasonal Influenza Adult Vaccine Market Share

    8    United States
    8.1    United States Seasonal Influenza Vaccinated Total Population
    8.1.1    United States Seasonal Influenza Vaccinated Child Population
    8.1.2    United States Seasonal Influenza Vaccinated Adult Population

    8.2    United States Seasonal Influenza Vaccine Market
    8.2.1    United States Seasonal Influenza Child Vaccine Market
    8.2.2    United States Seasonal Influenza Adult Vaccine Market

    9    Netherlands
    9.1    Netherlands Seasonal Influenza Vaccinated Total Population
    9.1.1    Netherlands Seasonal Influenza Vaccinated Child Population
    9.1.2    Netherlands Seasonal Influenza Vaccinated Adult Population

    9.2    Netherlands Seasonal Influenza Vaccine Market
    9.2.1    Netherlands Seasonal Influenza Child Vaccine Market
    9.2.2    Netherlands Seasonal Influenza Adult Vaccine Market

    10    Denmark
    10.1    Denmark Seasonal Influenza Vaccinated Total Population
    10.1.1    Denmark Seasonal Influenza Vaccinated Child Population
    10.1.2    Denmark Seasonal Influenza Vaccinated Adult Population

    10.2    Denmark Seasonal Influenza Vaccine Market
    10.2.1    Denmark Seasonal Influenza Child Vaccine Market
    10.2.2    Denmark Seasonal Influenza Adult Vaccine Market

    11    Estonia
    11.1    Estonia Seasonal Influenza Vaccinated Total Population
    11.1.1    Estonia Seasonal Influenza Vaccinated Child Population
    11.1.2    Estonia Seasonal Influenza Vaccinated Adult Population

    11.2    Estonia Seasonal Influenza Vaccine Market
    11.2.1    Estonia Seasonal Influenza Child Vaccine Market
    11.2.2    Estonia Seasonal Influenza Adult Vaccine Market

    12    Finland
    12.1    Finland Seasonal Influenza Vaccinated Total Population
    12.1.1    Finland Seasonal Influenza Vaccinated Child Population
    12.1.2    Finland Seasonal Influenza Vaccinated Adult Population

    12.2    Finland Seasonal Influenza Vaccine Market
    12.2.1    Finland Seasonal Influenza Child Vaccine Market
    12.2.2    Finland Seasonal Influenza Adult Vaccine Market

    13    Germany
    13.1    Germany Seasonal Influenza Vaccinated Total Population
    13.1.1    Germany Seasonal Influenza Vaccinated Child Population
    13.1.2    Germany Seasonal Influenza Vaccinated Adult Population

    13.2    Germany Seasonal Influenza Vaccine Market
    13.2.1    Germany Seasonal Influenza Child Vaccine Market
    13.2.2    Germany Seasonal Influenza Adult Vaccine Market

    14    France
    14.1    France Seasonal Influenza Vaccinated Total Population
    14.1.1    France Seasonal Influenza Vaccinated Child Population
    14.1.2    France Seasonal Influenza Vaccinated Adult Population

    14.2    France Seasonal Influenza Vaccine Market Analysis
    14.2.1    France Seasonal Influenza Child Vaccine Market
    14.2.2    France Seasonal Influenza Adult Vaccine Market

    15    Hungary
    15.1    Hungary Seasonal Influenza Vaccinated Total Population
    15.1.1    Hungary Seasonal Influenza Vaccinated Child Population
    15.1.2    Hungary Seasonal Influenza Vaccinated Adult Population

    15.2    Hungary Seasonal Influenza Vaccine Market
    15.2.1    Hungary Seasonal Influenza Child Vaccine Market
    15.2.2    Hungary Seasonal Influenza Adult Vaccine Market

    16    Iceland
    16.1    Iceland Seasonal Influenza Vaccinated Total Population
    16.1.1    Iceland Seasonal Influenza Vaccinated Child Population
    16.1.2    Iceland Seasonal Influenza Vaccinated Adult Population

    16.2    Iceland Seasonal Influenza Vaccine Market
    16.2.1    Iceland Seasonal Influenza Child Vaccine Market
    16.2.2    Iceland Seasonal Influenza Adult Vaccine Market

    17    Ireland
    17.1    Ireland Seasonal Influenza Vaccinated Total Population
    17.1.1    Ireland Seasonal Influenza Vaccinated Child Population
    17.1.2    Ireland Seasonal Influenza Vaccinated Adult Population

    17.2    Ireland Seasonal Influenza Vaccine Market
    17.2.1    Ireland Seasonal Influenza Child Vaccine Market
    17.2.2    Ireland Seasonal Influenza Adult Vaccine Market

    18    Italy
    18.1    Italy Seasonal Influenza Vaccinated Total Population
    18.1.1    Italy Seasonal Influenza Vaccinated Child Population
    18.1.2    Italy Seasonal Influenza Vaccinated Adult Population

    18.2    Italy Seasonal Influenza Vaccine Market
    18.2.1    Italy Seasonal Influenza Child Vaccine Market
    18.2.2    Italy Seasonal Influenza Adult Vaccine Market

    19    Latvia
    19.1    Latvia Seasonal Influenza Vaccinated Total Population
    19.1.1    Latvia Seasonal Influenza Vaccinated Child Population
    19.1.2    Latvia Seasonal Influenza Vaccinated Adult Population

    19.2    Latvia Seasonal Influenza Vaccine Market
    19.2.1    Latvia Seasonal Influenza Child Vaccine Market
    19.2.2    Latvia Seasonal Influenza Adult Vaccine Market

    20    Lithuania
    20.1    Lithuania Seasonal Influenza Vaccinated Total Population
    20.1.1    Lithuania Seasonal Influenza Vaccinated Child Population
    20.1.2    Lithuania Seasonal Influenza Vaccinated Adult Population

    20.2    Lithuania Seasonal Influenza Vaccine Market
    20.2.1    Lithuania Seasonal Influenza Child Vaccine Market
    20.2.2    Lithuania Seasonal Influenza Adult Vaccine Market

    21    Luxembourg
    21.1    Luxembourg Seasonal Influenza Vaccinated Total Population
    21.1.1    Luxembourg Seasonal Influenza Vaccinated Child Population
    21.1.2    Luxembourg Seasonal Influenza Vaccinated Adult Population

    21.2    Luxembourg Seasonal Influenza Vaccine Market
    21.2.1    Luxembourg Seasonal Influenza Child Vaccine Market
    21.2.2    Luxembourg Seasonal Influenza Adult Vaccine Market

    22    Malta
    22.1    Malta Seasonal Influenza Vaccinated Total Population
    22.1.1    Malta Seasonal Influenza Vaccinated Child Population
    22.1.2    Malta Seasonal Influenza Vaccinated Adult Population

    22.2    Malta Seasonal Influenza Vaccine Market
    22.2.1    Malta Seasonal Influenza Child Vaccine Market
    22.2.2    Malta Seasonal Influenza Adult Vaccine Market

    23    Norway
    23.1    Norway Seasonal Influenza Vaccinated Total Population
    23.1.1    Norway Seasonal Influenza Vaccinated Child Population
    23.1.2    Norway Seasonal Influenza Vaccinated Adult Population

    23.2    Norway Seasonal Influenza Vaccine Market
    23.2.1    Norway Seasonal Influenza Child Vaccine Market
    23.2.2    Norway Seasonal Influenza Adult Vaccine Market

    24    Poland
    24.1    Poland Seasonal Influenza Vaccinated Total Population
    24.1.1    Poland Seasonal Influenza Vaccinated Child Population
    24.1.2    Poland Seasonal Influenza Vaccinated Adult Population

    24.2    Poland Seasonal Influenza Vaccine Market
    24.2.1    Poland Seasonal Influenza Child Vaccine Market
    24.2.2    Poland Seasonal Influenza Adult Vaccine Market

    25    Portugal
    25.1    Portugal Seasonal Influenza Vaccinated Total Population
    25.1.1    Portugal Seasonal Influenza Vaccinated Child Population
    25.1.2    Portugal Seasonal Influenza Vaccinated Adult Population

    25.2    Portugal Seasonal Influenza Vaccine Market
    25.2.1    Portugal Seasonal Influenza Child Vaccine Market
    25.2.2    Portugal Seasonal Influenza Adult Vaccine Market

    26    Romania
    26.1    Romania Seasonal Influenza Vaccinated Total Population
    26.1.1    Romania Seasonal Influenza Vaccinated Child Population
    26.1.2    Romania Seasonal Influenza Vaccinated Adult Population

    26.2    Romania Seasonal Influenza Vaccine Market
    26.2.1    Romania Seasonal Influenza Child Vaccine Market
    26.2.2    Romania Seasonal Influenza Adult Vaccine Market

    27    Slovakia
    27.1    Slovakia Seasonal Influenza Vaccinated Total Population
    27.1.1    Slovakia Seasonal Influenza Vaccinated Child Population
    27.1.2    Slovakia Seasonal Influenza Vaccinated Adult Population

    27.2    Slovakia Seasonal Influenza Vaccine Market
    27.2.1    Slovakia Seasonal Influenza Child Vaccine Market
    27.2.2    Slovakia Seasonal Influenza Adult Vaccine Market

    28    Slovenia
    28.1    Slovenia Seasonal Influenza Vaccinated Total Population
    28.1.1    Slovenia Seasonal Influenza Vaccinated Child Population
    28.1.2    Slovenia Seasonal Influenza Vaccinated Adult Population

    28.2    Slovenia Seasonal Influenza Vaccine Market
    28.2.1    Slovenia Seasonal Influenza Child Vaccine Market
    28.2.2    Slovenia Seasonal Influenza Adult Vaccine Market

    29    Spain
    29.1    Spain Seasonal Influenza Vaccinated Total Population
    29.1.1    Spain Seasonal Influenza Vaccinated Child Population
    29.1.2    Spain Seasonal Influenza Vaccinated Adult Population

    29.2    Spain Seasonal Influenza Vaccine Market
    29.2.1    Spain Seasonal Influenza Child Vaccine Market
    29.2.2    Spain Seasonal Influenza Adult Vaccine Market

    30    Sweden
    30.1    Sweden Seasonal Influenza Vaccinated Total Population
    30.1.1    Sweden Seasonal Influenza Vaccinated Child Population
    30.1.2    Sweden Seasonal Influenza Vaccinated Adult Population

    30.2    Sweden Seasonal Influenza Vaccine Market
    30.2.1    Sweden Seasonal Influenza Child Vaccine Market
    30.2.2    Sweden Seasonal Influenza Adult Vaccine Market

    31    United Kingdom
    31.1    United Kingdom Seasonal Influenza Vaccinated Total Population
    31.1.1    United Kingdom Seasonal Influenza Vaccinated Child Population
    31.1.2    United Kingdom Seasonal Influenza Vaccinated Adult Population

    31.2    United Kingdom Seasonal Influenza Vaccine Market
    31.2.1    United Kingdom Seasonal Influenza Child Vaccine Market
    31.2.2    United Kingdom Seasonal Influenza Adult Vaccine Market

    32    China
    32.1    China Seasonal Influenza Vaccinated Total Population
    32.1.1    China Seasonal Influenza Vaccinated Child Population
    32.1.2    China Seasonal Influenza Vaccinated Adult Population

    32.2    China Seasonal Influenza Vaccine Market
    32.2.1    China Seasonal Influenza Child Vaccine Market
    32.2.2    China Seasonal Influenza Adult Vaccine Market

    33    India
    33.1    India Seasonal Influenza Vaccinated Total Population
    33.1.1    India Seasonal Influenza Vaccinated Child Population
    33.1.2    India Seasonal Influenza Vaccinated Adult Population

    33.2    India Seasonal Influenza Vaccine Market
    33.2.1    India Seasonal Influenza Child Vaccine Market
    33.2.2    India Seasonal Influenza Adult Vaccine Market

    34    Brazil
    34.1    Brazil Seasonal Influenza Vaccinated Total Population
    34.1.1    Brazil Seasonal Influenza Vaccinated Child Population
    34.1.2    Brazil Seasonal Influenza Vaccinated Adult Population

    34.2    Brazil Seasonal Influenza Vaccine Market
    34.2.1    Brazil Seasonal Influenza Child Vaccine Market
    34.2.2    Brazil Seasonal Influenza Adult Vaccine Market

    35    Japan
    35.1    Japan Seasonal Influenza Vaccinated Total Population
    35.1.1    Japan Seasonal Influenza Vaccinated Child Population
    35.1.2    Japan Seasonal Influenza Vaccinated Adult Population

    35.2    Japan Seasonal Influenza Vaccine Market
    35.2.1    Japan Seasonal Influenza Child Vaccine Market
    35.2.2    Japan Seasonal Influenza Adult Vaccine Market

    36    Australia
    36.1    Australia Seasonal Influenza Vaccinated Total Population
    36.1.1    Australia Seasonal Influenza Vaccinated Child Population
    36.1.2    Australia Seasonal Influenza Vaccinated Adult Population

    36.2    Australia Seasonal Influenza Vaccine Market
    36.2.1    Australia Seasonal Influenza Child Vaccine Market
    36.2.2    Australia Seasonal Influenza Adult Vaccine Market

    37    New Zealand
    37.1    New Zealand Seasonal Influenza Vaccinated Total Population
    37.1.1    New Zealand Seasonal Influenza Vaccinated Child Population
    37.1.2    New Zealand Seasonal Influenza Vaccinated Adult Population

    37.2    New Zealand Seasonal Influenza Vaccine Market
    37.2.1    New Zealand Seasonal Influenza Child Vaccine Market
    37.2.2    New Zealand Seasonal Influenza Adult Vaccine Market

    38    Worldwide – Seasonal Influenza Vaccine Brand Sales and Forecast
    38.1    Vaxigrip / Fluzone Vaccine Sales and Forecast

    38.2    Fluarix / Flulaval Vaccine Sales and Forecast

    38.3    FluMist/Fluenz Vaccine Sales and Forecast

    38.4    Afluria / Fluvax and Fluvirin / Flucelvax Vaccine Sales and Forecast

    38.5    Anflu Vaccine Sales and Forecast

    39    Seasonal Influenza Vaccine – Growth Drivers
    39.1    Growing Awareness on Seasonal Influenza Vaccination

    39.2    Vaccine Companies Plan to Augment Flu Vaccine Production

    39.3    Increased Engagement by the Governments

    40    Seasonal Influenza Vaccine – Challenges
    40.1    Regulatory Issues with Novel Influenza Vaccines

    40.2    Lack of Healthcare Infrastructure

    40.3    Limited Reimbursement and Access to the Vaccines

    40.4    China Tightens Rules on Vaccine Distribution

    List of Figures    
        
    Figure 3‑1: Structure of Influenza Virus    

    Figure 5‑1: Worldwide - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016    
    Figure 5‑2: Worldwide – Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022    
    Figure 5‑3: Worldwide - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 5‑4: Worldwide – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 5‑5: Worldwide - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 5‑6: Worldwide – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    

    Figure 6‑1: Worldwide - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 6‑2: Worldwide – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 6‑3: Worldwide - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 6‑4: Worldwide – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 6‑5: Worldwide - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 6‑6: Worldwide – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 8‑1: United States – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 – 2016    
    Figure 8‑2: United States – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 – 2022    
    Figure 8‑3: United States - Seasonal Influenza Vaccinated Child Population (Thousands), 2011 – 2016    
    Figure 8‑4: United States – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 – 2022    
    Figure 8‑5: United States - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 – 2016    
    Figure 8‑6: United States – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022    
    Figure 8‑7: United States - Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016    
    Figure 8‑8: United States - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022    
    Figure 8‑9: United States - Seasonal Influenza Children Vaccine Market (Million US$), 2011 – 2016    
    Figure 8‑10: United States - Seasonal Influenza Child Vaccine Market (Million US$), 2017 – 2022    
    Figure 8‑11: United States - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 – 2016    
    Figure 8‑12: United States - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022    

    Figure 9‑1: Netherlands - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 9‑2: Netherlands – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 9‑3: Netherlands - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 9‑4: Netherlands – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 9‑5: Netherlands - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 9‑6: Netherlands – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 9‑7: Netherlands - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 9‑8: Netherlands – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 9‑9: Netherlands - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 9‑10: Netherlands – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 9‑11: Netherlands - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 9‑12: Netherlands – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 10‑1: Denmark - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 10‑2: Denmark – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 10‑3: Denmark - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 10‑4: Denmark – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 10‑5: Denmark - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 10‑6: Denmark – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 10‑7: Denmark - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 10‑8: Denmark – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 10‑9: Denmark - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 10‑10: Denmark – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 10‑11: Denmark - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 10‑12: Denmark – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 11‑1: Estonia – Seasonal Influenza Vaccinated Population (Thousand), 2011 – 2016    
    Figure 11‑2: Estonia –Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 – 2022    
    Figure 11‑3: Estonia- Seasonal Influenza Vaccinated Child Population (Thousand), 2011 – 2016    
    Figure 11‑4: Estonia- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 11‑5: Estonia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 11‑6: Estonia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 11‑7: Estonia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 11‑8: Estonia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 11‑9: Estonia - Seasonal Influenza Children Vaccine Market (Thousand US$), 2011 – 2016    
    Figure 11‑10: Estonia - Forecast for Seasonal Influenza Children Vaccine Market (Thousand US$), 2017 – 2022    
    Figure 11‑11: Estonia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 11‑12: Estonia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 12‑1: Finland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 12‑2: Finland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 12‑3: Finland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 12‑4: Finland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 12‑5: Finland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 12‑6: Finland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 12‑7: Finland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 12‑8: Finland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 12‑9: Finland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 12‑10: Finland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 12‑11: Finland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 12‑12: Finland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 13‑1: Germany – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 13‑2: Germany - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 13‑3: Germany – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 13‑4: Germany - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 13‑5: Germany – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 13‑6: Germany - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 13‑7: Germany – Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 13‑8: Germany - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022    
    Figure 13‑9: Germany – Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 13‑10: Germany - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 13‑11: Germany- Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 13‑12: Germany- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022    

    Figure 14‑1: France – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 14‑2: France - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 14‑3: France - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 14‑4: France- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 14‑5: France - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 14‑6: France - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 14‑7: France - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 14‑8: France - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022    
    Figure 14‑9: France - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 14‑10: France - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 14‑11: France - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 14‑12: France - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022    

    Figure 15‑1: Hungary - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 15‑2: Hungary – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 15‑3: Hungary - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 15‑4: Hungary – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 15‑5: Hungary – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 15‑6: Hungary- Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 15‑7: Hungary – Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 15‑8: Hungary – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 15‑9: Hungary - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 15‑10: Hungary – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 15‑11: Hungary – Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 – 2016    
    Figure 15‑12: Hungary - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 – 2022    

    Figure 16‑1: Iceland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 16‑2: Iceland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 16‑3: Iceland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 16‑4: Iceland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 16‑5: Iceland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 16‑6: Iceland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022    
    Figure 16‑7: Iceland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 16‑8: Iceland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 16‑9: Iceland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 16‑10: Iceland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 16‑11: Iceland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 16‑12: Iceland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 17‑1: Ireland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 17‑2: Ireland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 17‑3: Ireland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 17‑4: Ireland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 17‑5: Ireland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 17‑6: Ireland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 17‑7: Ireland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 17‑8: Ireland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 17‑9: Ireland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 17‑10: Ireland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 17‑11: Ireland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 – 2016    
    Figure 17‑12: Ireland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 – 2022    

    Figure 18‑1: Italy - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 18‑2: Italy - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 18‑3: Italy - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 18‑4: Italy - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 18‑5: Italy - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 18‑6: Italy - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 18‑7: Italy - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 18‑8: Italy - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022    
    Figure 18‑9: Italy - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 18‑10: Italy - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 18‑11: Italy - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 18‑12: Italy- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022    

    Figure 19‑1: Latvia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 19‑2: Latvia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 19‑3: Latvia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 19‑4: Latvia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 19‑5: Latvia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 – 2016    
    Figure 19‑6: Latvia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022    
    Figure 19‑7: Latvia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 19‑8: Latvia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 19‑9: Latvia- Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 19‑10: Latvia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 – 2022    

    Figure 20‑1: Lithuania - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 20‑2: Lithuania - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 20‑3: Lithuania - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 20‑4: Lithuania - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 20‑5: Lithuania - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 20‑6: Lithuania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 20‑7: Lithuania – Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 20‑8: Lithuania – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 20‑9: Lithuania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 20‑10: Lithuania – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 20‑11: Lithuania – Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 20‑12: Lithuania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 21‑1: Luxembourg - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 21‑2: Luxembourg – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 21‑3: Luxembourg - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 21‑4: Luxembourg – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 21‑5: Luxembourg - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 21‑6: Luxembourg – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 21‑7: Luxembourg - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 21‑8: Luxembourg – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 – 2022    
    Figure 21‑9: Luxembourg - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 21‑10: Luxembourg – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 21‑11: Luxembourg - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 -2016    
    Figure 21‑12: Luxembourg – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 -2022    

    Figure 22‑1: Malta - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 22‑2: Malta – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 22‑3: Malta – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 22‑4: Malta – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 22‑5: Malta – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 22‑6: Malta – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 22‑7: Malta - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 22‑8: Malta – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 22‑9: Malta – Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 22‑10: Malta – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 22‑11: Malta - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 22‑12: Malta – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 23‑1: Norway - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 23‑2: Norway – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 23‑3: Norway - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 – 2016    
    Figure 23‑4: Norway – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 – 2022    
    Figure 23‑5: Norway - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 23‑6: Norway – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 23‑7: Norway - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 23‑8: Norway – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 23‑9: Norway - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 23‑10: Norway – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 23‑11: Norway - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 23‑12: Norway – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 24‑1: Poland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 – 2016    
    Figure 24‑2: Poland- Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 24‑3: Poland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 24‑4: Poland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 24‑5: Poland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 24‑6: Poland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 24‑7: Poland - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 24‑8: Poland - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022    
    Figure 24‑9: Poland - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 24‑10: Poland - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 24‑11: Poland - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 24‑12: Poland - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017- 2022    

    Figure 25‑1: Portugal - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 25‑2: Portugal - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 25‑3: Portugal - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 25‑4: Portugal - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 25‑5: Portugal - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 25‑6: Portugal - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 25‑7: Portugal - Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016    
    Figure 25‑8: Portugal - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022    
    Figure 25‑9: Portugal - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 25‑10: Portugal - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 25‑11: Portugal - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 25‑12: Portugal - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022    

    Figure 26‑1: Romania - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 26‑2: Romania – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 26‑3: Romania – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 26‑4: Romania – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 26‑5: Romania – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 – 2016    
    Figure 26‑6: Romania – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022    
    Figure 26‑7: Romania - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 26‑8: Romania – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 26‑9: Romania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 26‑10: Romania – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 26‑11: Romania – Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 26‑12: Romania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 27‑1: Slovakia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 27‑2: Slovakia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 27‑3: Slovakia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 27‑4: Slovakia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 27‑5: Slovakia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 27‑6: Slovakia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 27‑7: Slovakia - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 27‑8: Slovakia - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 27‑9: Slovakia - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 27‑10: Slovakia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 27‑11: Slovakia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 27‑12: Slovakia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 28‑1: Slovenia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 28‑2: Slovenia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 28‑3: Slovenia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 28‑4: Slovenia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 28‑5: Slovenia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 28‑6: Slovenia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 28‑7: Slovenia - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 28‑8: Slovenia - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 28‑9: Slovenia - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 – 2016    
    Figure 28‑10: Slovenia - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 – 2022    
    Figure 28‑11: Slovenia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 28‑12: Slovenia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 29‑1: Spain – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 29‑2: Spain – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 29‑3: Spain – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 29‑4: Spain – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 29‑5: Spain - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 29‑6: Spain – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 29‑7: Spain - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 29‑8: Spain – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022    
    Figure 29‑9: Spain –Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 29‑10: Spain – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 29‑11: Spain - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 29‑12: Spain – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022    

    Figure 30‑1: Sweden - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016    
    Figure 30‑2: Sweden – Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022    
    Figure 30‑3: Sweden - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 30‑4: Sweden – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 30‑5: Sweden - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 30‑6: Sweden – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 30‑7: Sweden - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 30‑8: Sweden – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 30‑9: Sweden - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 30‑10: Sweden – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 30‑11: Sweden - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 30‑12: Sweden – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 31‑1: United Kingdom - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 31‑2: United Kingdom – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 31‑3: United Kingdom - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 31‑4: United Kingdom – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 31‑5: United Kingdom - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 31‑6: United Kingdom – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 31‑7: List of Seasonal Influenza Vaccines for the 2016/17 Influenza Season    
    Figure 31‑8: United Kingdom - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 31‑9: United Kingdom – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022    
    Figure 31‑10: United Kingdom - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 31‑11: United Kingdom – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 31‑12: United Kingdom - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 31‑13: United Kingdom – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022    

    Figure 32‑1: China - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 32‑2: China - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 32‑3: China - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 32‑4: China - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 32‑5: China - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 32‑6: China- Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017- 2022    
    Figure 32‑7: China- Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 32‑8: China - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022    
    Figure 32‑9: China - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 32‑10: China - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 32‑11: China - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 – 2016    
    Figure 32‑12: China - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022    

    Figure 33‑1: India - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 33‑2: India - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 33‑3: India - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 33‑4: India- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 33‑5: India - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 33‑6: India - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 33‑7: India – Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 33‑8: India - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022    
    Figure 33‑9: India - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 33‑10: India - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 33‑11: India - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 33‑12: India - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022    

    Figure 34‑1: Brazil - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 34‑2: Brazil – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 – 2022    
    Figure 34‑3: Brazil - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 34‑4: Brazil – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 34‑5: Brazil - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 34‑6: Brazil – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 34‑7: Brazil - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 34‑8: Brazil – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022    
    Figure 34‑9: Brazil - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 34‑10: Brazil – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 34‑11: Brazil - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 34‑12: Brazil – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022    

    Figure 35‑1: Japan - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 35‑2: Japan – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 35‑3: Japan - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 35‑4: Japan – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 35‑5: Japan - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 35‑6: Japan – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 35‑7: Japan - Seasonal Influenza Vaccine Market Analysis (Million US$), 2011 - 2016    
    Figure 35‑8: Japan – Forecast for Seasonal Influenza Vaccine Market Analysis (Million US$), 2017 - 2022    
    Figure 35‑9: Japan - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 35‑10: Japan – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 35‑11: Japan - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016    
    Figure 35‑12: Japan – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022    

    Figure 36‑1: Australia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 36‑2: Australia – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 36‑3: Australia – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 36‑4: Australia – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022    
    Figure 36‑5: Australia – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 36‑6: Australia – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 36‑7: Registered Six Vaccines List    
    Figure 36‑8: Australia – Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016    
    Figure 36‑9: Australia – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022    
    Figure 36‑10: Australia – Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016    
    Figure 36‑11: Australia – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022    
    Figure 36‑12: Australia – Seasonal Influenza Adult Vaccine Market (Million US$), 2011 – 2016    
    Figure 36‑13: Australia – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022    

    Figure 37‑1: The Difference between Influenza and a Common Cold    
    Figure 37‑2: New Zealand – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016    
    Figure 37‑3: New Zealand – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022    
    Figure 37‑4: New Zealand - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016    
    Figure 37‑5: New Zealand – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 – 2022    
    Figure 37‑6: New Zealand - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016    
    Figure 37‑7: New Zealand – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022    
    Figure 37‑8: New Zealand - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 37‑9: New Zealand – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 37‑10: New Zealand - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 37‑11: New Zealand – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022    
    Figure 37‑12: New Zealand – Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016    
    Figure 37‑13: New Zealand – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022    

    Figure 38‑1: Worldwide – Vaxigrip/Fluzone Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016    
    Figure 38‑2: Worldwide – Forecast for Vaxigrip/Fluzone Seasonal Influenza Vaccine Market (Million US$), 2017– 2022    
    Figure 38‑3: Worldwide – Fluarix / Flulaval Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016    
    Figure 38‑4: Worldwide – Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Market (Million US$), 2017– 2022    
    Figure 38‑5: Worldwide – Flumist/Fluenz Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016    
    Figure 38‑6: Worldwide – Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022    
    Figure 38‑7: Worldwide – Afluria/Fluvax and Fluvirin/Flucelvax Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016    
    Figure 38‑8: Worldwide – Afluria/Fluvax and Fluvirin/Flucelvax Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016    
    Figure 38‑9: Worldwide – Anflu Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016    
    Figure 38‑10: Worldwide – Forecast for Anflu Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022    

    Figure 39‑1: Vaccine Manufacturers – Influenza Vaccine Production (Million Doses), 2013-2015    

    Figure 40‑1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019    
        
        
        
        
        
    List of Tables    
        
    Table 4‑1: Notable Influenza Pandemics    

    Table 7‑1: Worldwide - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016    
    Table 7‑2: Worldwide – Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022    
    Table 7‑3: Worldwide - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016    
    Table 7‑4: Worldwide – Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022    
    Table 7‑5: Worldwide - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016    
    Table 7‑6: Worldwide – Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022    


    Related Products